Oviva AG

Oviva is the leading digital healthcare provider for diet and lifestyle related health conditions such as obesity and type 2 diabetes in Europe. Our technology-driven approach is clinically validated in published trials and by over 120’000 patients to date to drive better outcomes and massively reduce associated healthcare costs.

Oviva is rapidly expanding in Switzerland, Germany, France and the UK, supported by a fresh $21m Series financing from leading VCs. Our go-to-market strategy is proven, a unique feature for a digital health startup and needs to be scaled massively in the next years to reach our vision to have meaningful impact in improving the health of patients with diabetes and obesity.